Tetratherix

Tetratherix company information, Employees & Contact Information

Explore related pages

Related company profiles:

[ASX:TTX] Tetratherix has developed a proprietary fluid matrix that is invisible to the body & does not induce any foreign body reaction to evolve regenerative medicine and targeted therapeutic delivery. Tetramatrix is a water based polymer solution that forms an adhesive hydrogel once administered to the body. The product is fully synthetic, biocompatible and resorbable. After a decade of development with meticulous polymer programing, Tetratherix is advancing the world of biopolymers by developing real world applications specific to multiple indications in an effort to change the lives of patients around the world.

Company Details

Employees
22
Founded
-
Address
Sydney, Nsw, Au
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Manager jobs.
HQ
Sydney, NSW
Looking for a particular Tetratherix employee's phone or email?

Tetratherix Questions

News

Tetratherix lists on ASX in $25M IPO - BioWorld MedTech

Tetratherix lists on ASX in $25M IPO BioWorld MedTech

‘Next Cochlear’ launches ASX float to sell its ‘medical Lego’ - AFR

‘Next Cochlear’ launches ASX float to sell its ‘medical Lego’ AFR

Tetratherix (TTX), Australia’s own ‘medical Lego’ - Rask Media

Tetratherix (TTX), Australia’s own ‘medical Lego’ Rask Media

Tetratherix jumps on debut, capping strong week of ASX listings” - AFR

Tetratherix jumps on debut, capping strong week of ASX listings” AFR

Tetratherix launches $25m IPO with plans for bone regeneration biotech roll-out in 2026 - Business News Australia

Tetratherix launches $25m IPO with plans for bone regeneration biotech roll-out in 2026 Business News Australia

Tetratherix launches $25 million IPO to fund biotech innovation in tissue healing | ASX:TTX - Proactive financial news

Tetratherix launches $25 million IPO to fund biotech innovation in tissue healing | ASX:TTX Proactive financial news

Tetratherix Hits the ASX: What Investors Need to Know About This Fresh Life Sciences Listing - Stocks Down Under

Tetratherix Hits the ASX: What Investors Need to Know About This Fresh Life Sciences Listing Stocks Down Under

Dr Boreham’s Crucible: ASX newbie Tetratherix plays it slow and steady - Stockhead

Dr Boreham’s Crucible: ASX newbie Tetratherix plays it slow and steady Stockhead

Thermoresponsive and Injectable Hydrogel for Tissue Agnostic Regeneration - Wiley Online Library

Thermoresponsive and Injectable Hydrogel for Tissue Agnostic Regeneration Wiley Online Library

Health Check: Tetratherix breaks biotech IPO drought with 13pc gain on debut - Stockhead

Health Check: Tetratherix breaks biotech IPO drought with 13pc gain on debut Stockhead

Scott Power: ASX health lifts to start FY26, Tetratherix ends IPO drought - Stockhead

Scott Power: ASX health lifts to start FY26, Tetratherix ends IPO drought Stockhead

Top Tetratherix Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant